Quick Answer
MIRA PHARMACEUTICALS, INC. reported Total Assets of $11.09 million for the year ending 2025.
- MIRA PHARMACEUTICALS, INC. showed an increase of +279.5% in Total Assets from 2024 to 2025.
- This data is from MIRA PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2023: $3.83 million | Q3 2023: $9.02 million | Q1 2024: $3.81 million | Q2 2024: $3.02 million | Q3 2024: $4.27 million | Q1 2025: $1.40 million | Q2 2025: $868.3 thousand | Q3 2025: $7.63 million.
- Over the full 4 years of available data (2022 to 2025), MIRA PHARMACEUTICALS, INC.'s Total Assets has grown by 1,192.8%.
- Historical annual values: Fiscal year 2025: $11.09 million | Fiscal year 2024: $2.92 million | Fiscal year 2023: $4.93 million | Fiscal year 2022: $858.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: